Looking to protect yourself and your family from whooping cough? You've come
to the right place.
With reported cases of pertussis, commonly referred to as whooping cough, the highest they
have been in 45 years1,2 and a sizable increase in adolescent and adult cases,3-5
it is wise to consider getting yourself immunized. By protecting yourself you are also protecting those
around you, especially those most vulnerable, such as infants.
The Centers for Disease Control and Prevention now recommend that adolescents and adults 11
through 64 years of age should receive a tetanus, diphtheria, and acellular pertussis, or Tdap,
booster shot.6,7 This is particularly important for those in close contact with vulnerable infants
(parents, siblings, grandparents, child-care givers, health-care professionals).
You can protect yourself against pertussis with ADACEL vaccine, a booster vaccine for
adolescents and adults 11 through 64 years of age. Not only does ADACEL vaccine protect
against pertussis, but it also offers the additional booster protection people need against
tetanus and diphtheria.
To find a health-care professional near you who can administer the vaccine, please enter your ZIP code, click on your state on the map below or select a state from the drop down.
Want to know more about why you need a Tdap booster? Click here to learn more
about transmission.
References: 1. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases—United States, 1994. Published Oct. 6, 1995, for MMWR.
1994;43(53):77. 2. CDC. Notice to readers: final 2004 reports of notifiable diseases. MMWR. 2005;54(31):770-780. 3. Güris D, Strebel PM, Bardenheier B, et al.
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996.Clin Infect Dis. 1999;28:1230-
1237. 4. CDC. Pertussis—United States, 1997-2000. MMWR. 2002;51:73-76. 5. CDC. Pertussis Surveillance Reports, Data on file. MKT11232-2. 6. CDC. Preventing
tetanus, diphtheria and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: recommendations of the
Advisory Committee on Immunization Practices (ACIP). MMWR. 2006;55(No. RR-3):22. 7. CDC. ACIP votes to recommend use of combined tetanus, diphtheria and
pertussis (Tdap) vaccine for adults. Available at: http://www.cdc.gov/nip/vaccine/tdap/tdap_adult_recs.pdf. Accessed March 22, 2006.
8. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: Who was the source? Pediatr Infect Dis J. 2004;23:985-989.
SAFETY INFORMATION
Indication Adacel vaccine is given as a single dose to people 11 through 64 years of age for active booster immunization for the prevention of tetanus (lockjaw), diphtheria, and pertussis (whooping cough).
Safety Information Side effects to Adacel vaccine include injection site pain, redness, and swelling; headache, body ache, tiredness, and fever. Tell your doctor if you have ever experienced a severe brain disorder, such as encephalopathy (altered consciousness) or Guillain-Barré syndrome (severe muscle weakness), after a previous dose of a tetanus toxoid- or pertussis-containing vaccine. Other side effects may occur. Vaccination with Adacel vaccine may not protect all people receiving the vaccine.
For more information about Adacel vaccine, talk to your health-care professional.
